Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2007-04-03
2007-04-03
Ungar, Susan (Department: 1642)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C424S184100, C424S185100, C530S827000, C530S828000
Reexamination Certificate
active
10019071
ABSTRACT:
The invention concerns a novel ICBP90 (Inverted CCAAT box binding protein 90) and its fragments, polynucleotides coding for said polypeptides and specific antibodies directed against said polypeptides. The invention also concerns methods and kits for diagnosing cell proliferation and compounds useful as medicine for preventing and/or treating pathology involving cell proliferation and in particular cancer.
REFERENCES:
patent: 6551795 (2003-04-01), Rubenfield et al.
patent: 6583275 (2003-06-01), Doucette-Stamm et al.
patent: WO 98 37207 (1998-08-01), None
patent: WO 99 38971 (1999-08-01), None
Bowie et al (Science, 1990, 257 : 1306-1310).
Drexler et al (Leukemia and Lymphoma, 1993, 9:1-25).
Embleton et al (Immunol Ser, 1984, 23:181-207).
Hsu (in Tissue Culture Methods and Applications, Kruse and Patterson, Eds, 1973, Academic Press, NY, see abstract, p. 764).
Gura (Science, 1997, 278:1041-1042).
Jain (Sci. Am., 1994, 271:58-65).
Curti (Crit. Rev. in Oncology/Hematology, 1993, 14:29-39.
Hartwell et al (Science, 1997, 278:1064-1068).
Ezzell (J. NIH Res, 1995, 7:46-49.
Spitler (Cancer Biotherapy, 1995, 10:1-3).
Boon (Adv Can Res, 1992, 58:177-210).
Burgess et al, (Journal of Cell Biology, 1990, 11: 2129-2138).
Lazar et al. Molecular and Cell Biology, 1988, 8: 1247-1252.
MPSRCH search report, 2004, us-10-019-071-2.olig.rai, pp. 1-2.
Ronchi, A et al, 1995, Nucleic acids Res, 23(22): 4565-72.
Liberati, C et al, 1999, J Mol Biol, 285(4) : 1441-55.
Sugiura et al, 2003, FEBS letters, 537(1-3): 58-62.
Hopfner, R et al, Jan. 1, 2000, Cancer Res, 60(1): 121-128.
MPSRCH search report, 2004, us-10-019-071-2.rup, pp. 1-2.
Austin, C. A., et al., “Novel HeLa topoisomerase II is the IIβ isoform: complete coding sequence and homology with other type II topoisomerases”, Biochimica et Biophysica Acta, vol. 1172, pp. 283-291 (1993).
Banerji, J., et al., “Expression of a β-Globin Gene Is Enhanced by Remote SV40 DNA Sequences”, Cell, vol. 27, pp. 299-308 (Part 1) (1981).
Barany, F., “Genetic disease detection and DNA amplification using cloned thermostable ligase”, Proc. Natl. Acad. Sci., vol. 88, pp. 189-193 (1991).
Boritzki, T. J., “Inhibition of Type II Topoisomerase By Fostriecin”, Biochemical Pharmacology, vol. 37, No. 21, pp. 4063-4068 (1988).
Brady, M. E., et al., “Tip60 Is a Nuclear Hormone Receptor Coactivator”, J. Biol. Chem., vol. 274, No. 25, pp. 17599-17604 (1999).
Brandt, T. L., et al., “c-Mybtrans-Activates the Human DNA Topoisomerase IIα Gene Promoter”, j. Biol. Chem., vol. 272, No. 10, pp. 6278-6284 (1997).
Brou, C., et al., “Distinct TFIID complexes mediate the effect of different transcriptional activators”, EMBO Journal, vol. 12, No. 2, pp. 489-499 (1993).
Buckholz, R. G., “Yeast systems for the expression of heterologous gene products”, Current Opinion in Biotechnology, vol. 4, pp. 538-542 (1993).
Burg, J. L., et al., “Single molecule detection of RNA reporter probes by amplification with Qβ replicase”, Molecular and Cellular Probes, vol. 10, pp. 257-271 (1996).
Chu, B. C. F., et al., “Synthesis of an amplifiable reporter RNA for bioassays”, Nucleic Acids Research, vol. 14, No. 14, pp. 5591-5603 (1986).
Chung, T. D. Y., et al., “Characterization and immunological identification of cDNA clones encoding two human DNA topoisomerase II isozymes”, Proc. Natl. Acad. Sci., vol. 86, pp. 9431-9435 (1989).
Darzynkiewicz, Z., et al., “Analysis of DNA Content and Cyclin Protein Expression in Studies of DNA Ploidy, Growth Fraction, Lymphocyte Stimulation, and the Cell Cycle”, Methods IN Cell Biolgoy, vol. 41, pp. 421-435 (1994).
Deffie, A. M., et al., “Direct Correlation between DNA Topoisomerase II Activity and Cytotoxicity in Adriamycin-sensitive and -resistant P388 Leukemia Cell Lines”, Cancer Research, vol. 49, No. 1, pp. 58-62 (1989).
De Vries, L., et al., “GAIP, a protein that specifically interacts with the trimeric G Protein Gαi3, is a member of a protein family with a highly conserved core domain”, Proc. Natl. Acad. Sci., vol. 92, pp. 11916-11920 (1995).
Devys, D., et al., “The FMR-1 protein is cytoplasmic most abundant in neurons and appears normal in carriers of a fragile X premutation”, Nature Genetics, vol. 4, pp. 335-340 (1993).
Drake, F. H., et al., “Biochemical and Pharmacological Properties of p170 and p180 Forms of Topoisomerase II”, Biochemistry, vol. 28, pp. 8154-8160 (1989).
Duck, P., et al., “Probe Amplifier System Based on Chimeric Cycling Oligonucleotides”, BioTechniques, vol. 9, No. 2, pp. 142-147 (1990).
Edwards, C. P., et al., “Current applications of COS cell based transient expression systems”, Current Opinion in Biotechnology, vol. 4, pp. 558-563 (1993).
Flouriot, G., et al., “Differentially Expressed Messenger RNA Isoforms of the Human Estrogen Receptor-α Gene Are Generated by Alternative Splicing and Promoter Usage”, Mol. Endo., vol. 12, No. 12, pp. 1939-1954 (1998).
Fry, A. M., et al., “Relationship between Topoisomerase II Level and Chemosensitivty in Human Tumor Cell Lines”, Cancer Research, vol. 51, pp. 6592-6595 (1991).
Furth, P. A., et al., “Gene Transfer into Somatic Tissues by Jet Injection”, Analytical Biochemistry, vol. 205, pp. 365-368 (1992).
Gaub, M-P., et al., “Nuclear Detection of Cellular Retinoic Acid Binding Proteins I and II with New Antibodies”, J. Histochem. & Cytochem., vol. 46, No. 10, pp. 1103-1111 (1998).
Goetz, J., et al., “Structure and Expression of the ATFα Gene”, J. Biol. Chem., vol. 271, No. 47, pp. 29589-29598 (1996).
Goswami, P. C., et al., “The Cell Cycle-Coupled Expression of Topoisomerase IIα during S Phase Is Regulated by mRNA Stability and Is Disrupted by Heat Shock or Ionizing Radiation”, Mole. And Cell. Biol., vol. 16, No. 4, pp. 1500-1508 (1996).
Grandien, K., “Determination of transcription start sites in the human estrogen receptor gene and identification of novel, tissue-specific, estrogen receptor-mRNA isoform”, Mole. & Cell. Endoc., vol. 116, pp. 207-212 (1996).
Griffin, C., et al., “Two Functionally Different Protein Isoforms Are Produced from the Chicken Estrogen Receptor-α Gene”, Mol. Endo., vol. 13, No. 9, pp. 1571-1587 (1999).
Gruber, S. B., et al., “Pathogenesis of Adenocarcinoma in Peutz-Jeghers Syndrome”, Cancer Research, vol. 58, pp. 5267-5270 (1998).
Guatelli, J. C., et al., “Isothermal,in vitroamplification of nucleic acids by a multienzyme reaction modeled after retroviral replication”, Proc. Natl. Acad. Sci., vol. 87, pp. 1874-1878 (1990).
Guinee, Jr., D. G., et al., “Comparison of DNA Topoisomerase IIα Expression in Small Cell and Nonsmall Cell Carcinoma of the Lung”, Cancer, vol. 78, No. 4, pp. 729-735 (1996).
Haddad, B. R., et al., “Identification of de novo chromosomal markers and derivatives by spectral karyotyping”, Hum Genet, vol. 103, pp. 619-625 (1998).
Heck, M. M. S., “Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle”, Proc. Natl. Acad. Sci., vol. 85, pp. 1086-1090 (1988).
Hochhauser, D., et al., “Cloning and Characterization of the 5′-Flanking Region of the Human Topoisomerase IIα Gene”, J. Biol. Chem., vol. 267, No. 26, pp. 18961-18965 (1992).
Höglund, M., et al., “Cytogenetic and Fluorescence In Situ Hybridization Analyses of Chromosome 19 Aberrations in Pancrastic Carcinomas: Frequent Loss of 19p13.3 and Gain of 19q13.1-13.2”, Genes, Chromosomes & Cancer, vol. 21, pp. 8-16 (1998).
Hromas, R., et al., “Hematopoietic Transcriptional Regulation by the Myeloid Zinc Finger Gene, MZF-1”,Molecular Aspects of Myeloid Stem Cell Development, pp. 159-164, Springer-Verlag (1996).
Inouye, C., et al.,
Bronner Christian
Hopfner Raphaël
Jeltsch Jean-Marc
Lutz Yves
Mousli Marc
Davis Minh-Tam
Foley & Lardner LLP
Institut National de la Sante et de la Recherche Medicale :(INSE
Ungar Susan
LandOfFree
ICBP90 polypeptide and its fragments and polynucleotides... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with ICBP90 polypeptide and its fragments and polynucleotides..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and ICBP90 polypeptide and its fragments and polynucleotides... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3790759